Borsati, Anita
Marotta, Angela
Ducoli, Valentina
Dodi, Alessandra
Belluomini, Lorenzo
Schena, Federico
Milella, Michele
Pilotto, Sara
Lanza, Massimo
Avancini, Alice
Funding for this research was provided by:
Università degli Studi di Verona
Article History
Received: 8 September 2022
Accepted: 21 February 2023
First Online: 15 July 2023
Declarations
:
: The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. M.M. reports personal fees from Pfizer, EUSA Pharma and Astra Zeneca, outside the submitted manuscript. S.P. received honoraria or speakers' fee from Astra Zeneca, Eli-Lilly, BMS, Boehringer Ingelheim, MSD and Roche, outside the submitted manuscript. All remaining authors declare that they have no competing interests.
: The local Ethics Committee for Clinical Trials has reviewed and approved the project (Prot. No. 33320).
: Written informed consent was signed by all participants recruited in the CHOiCE project and renewed before each focus group discussion in a verbal manner.